Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafu... Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.9 | 4.26742532006 | 21.09 | 22.675 | 19.87 | 123335 | 21.41046808 | CS |
4 | -1.21 | -5.21551724138 | 23.2 | 28.42 | 19.87 | 135742 | 24.44416865 | CS |
12 | 8.6 | 64.2270351008 | 13.39 | 28.42 | 12.63 | 86757 | 21.75937907 | CS |
26 | 10.29 | 87.9487179487 | 11.7 | 28.42 | 10.14 | 49572 | 19.50391614 | CS |
52 | 7.59 | 52.7083333333 | 14.4 | 28.42 | 10.004 | 237370 | 15.79809091 | CS |
156 | 5.19 | 30.8928571429 | 16.8 | 42 | 8 | 696132 | 22.7981951 | CS |
260 | -54.81 | -71.3671875 | 76.8 | 89 | 8 | 614598 | 30.26245352 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales